Share this:
Email this page Share this on LinkedIn Share this on Twitter Share with your XING network | print this page

EuroMedtech™ 2012 Program

The preliminary program for EuroMedtech™ 2012 will be available soon

EuroMedtech 2011 program

Additional Program Preceding EuroMedtech 2011
Special Course for Company Executives interested in the Chinese and US markets click here

Sunday, May 15, 2011

18:30 Palazzo Birago di Borgaro EuroMedtech™ 2011 Welcome Reception

All EuroMedtech attendees are cordially invited to join us for the Welcome Reception.

Palazzo Birago di Borgaro
Via Carlo Alberto 16, 10123 Turin, Italy (map)

Palazzo Birago di Borgaro is one of the most refined and well known examples of Piedmontese Baroque architecture, designed by the renowned artist Filippo Juvarra and restored in 1989.

The Torino Chamber of Commerce welcomes attendees to an amazing guided “tour of taste” featuring typical Piedmont foods and wines, selected from the local “Masters of Taste” and DOC wine producers. Discover more on "Masters of Taste" and "Torino DOC".

Virtual Tour (click here)

You can pick up your badge at the Welcome Reception.

Sponsored by:
Torino Chamber of Commerce Torino Chamber of Commerce

Monday, May 16, 2011

07:30
Convention Center of the WTC Grenoble
more info ►
Registration Opens/Continental Breakfast
09:00–10:00 Panel Discussion
Making the Deal: Perspectives From the Experienced

M&A activity picked up speed in 2010 but dealmaking is looking very different after the downturn. Examining deals from last year, this panel will look at the ins and outs of making a deal in the post recession market. How are new pressures, such as a buyer preference for profit-making companies, affecting M&A and how can a young company position itself in a buyer's market? What new strategies are being used to decrease deal risk? And are there new players on the field that young companies and their investors can turn to for exit possibilities? Perspectives from both sides of the table will illustrate the hurdles facing M&A and collaborative transactions in a new healthcare ecosystem.

Moderator:
Olivier Litzka – Partner, Edmond de Rothschild Investment

Panelists:
  • Simon Cartmell – Executive Chairman, OSspray
  • Laurent Grandidier – VP Sales and Marketing, Endosense
  • Nigel Pitchford – Partner, DFJ Esprit
  • Crispin Simon – formerly CEO, BioCompatibles and Executive Chairman, Occam Medical Ventures
Share this: Email this page Share this on LinkedIn Share this on Twitter
09:00–18:00
One-to-one Meetings
10:15–11:00 Company Presentations
11:15–11:30

Welcome Remarks

  • Carola Schropp – President, EBD Group
  • Alessandro Barberis – President, Torino Chamber of Commerce
  • Antonio Marco D’Acri – Province of Torino Councillor for Budget, Human Resources and International Affairs
  • Giuseppe Donato – President, Piemonte Agency for Investments, Export and Tourism
11:30–12:45 Opening Plenary Session
Pulse of the Industry: The Emergence of a "Health Outcomes Ecosystem"

2010 was a year of changes and challenges in the medtech area, all of which will affect the ways companies do business in 2011 and beyond. Faced with a struggling global economy, an uncertain regulatory environment in the largest medtech market, and a decrease in investor funds, how can the medtech industry retain innovation levels and continued growth? Starting with a half year update on Ernst & Young's annual Pulse of the Industry report, Heinrich Christen will lead this expert panel in a discussion of the different pressures creating a "health outcomes ecosystem" and how this new business model will change medtech companies in the future. Where are the possibilities for growth? What strategies must traditional companies adopt to succeed in this new environment? And how will a more collaborative approach to doing business benefit companies, investors and, ultimately, patients?

Moderator:
Heinrich Christen – Partner and Industry Leader, Medical Devices EMEIA, Ernst & Young

Panelists:
  • Markus Christen – Head of Business Development, Patient Franchises, Molecular Diagnostics Liaison, Novartis Pharma
  • Jason Hillenbach – Associate Director, Global Life Sciences Center, Ernst & Young
  • Tim Lenihan – CEO, MD Start
  • Josep Ll. Sanfeliu – Partner, Ysios Capital Partners
Share this: Email this page Share this on LinkedIn Share this on Twitter
12:45–13:30 Luncheon
13:30–14:30 Panel Discussion
A Business Model to Grow With: The Commercialization of Telehealthcare Technologies

One of the most exciting growth areas within the medtech industry is undoubtedly telehealthcare technologies. Encompassing remote monitoring, services that allow for greater flexibility in physician/patient interaction, and wellness technologies, telehealthcare combines medtech expertise with ICT tools. Expectations are high, with many analysts viewing it as the way health systems can deal with some of the pressures to be more efficient and cost-effective. But hurdles still remain before the telehealthcare explosion can be realized, not the least of which is the lack of a business model(s). This panel will explore some of the options being used today and discuss how the traditional business model could change to increase interplay among elective, statutory and insurance based systems to exploit the potential of this developing sector.

Moderator:
Sue Dunkerton – Co-Director, HealthTech & Medicines KTN

Panelists:
  • Emmanuele Angione – Head of Operations, WIN
  • Tony Davis – CEO, MedilinkWM and Chair, MedilinkUK
  • Bill McKeon – CEO, Cellnovo
Share this: Email this page Share this on LinkedIn Share this on Twitter
14:45–16:45 Company Presentations
17:00–18:00 Panel Discussion
Disruptive Innovation in Neuromodulation

With an aging population comes chronic conditions, not the least of which is pain. Pain management was the original application of neuromodulation, allowing the current demographic shift to propel a number of developments in this area. In addition to more effective and less invasive devices, new therapeutic applications of neuromodulation have also been explored and developed in conditions from obesity to Parkinson's disease. This panel will examine the newest developments in neuromodulation therapy, including deep brain stimulation and sacral nerve stimulation, the materials, technologies and collaborations that are needed for these new developments to succeed, as well as what therapies will drive future growth.

Moderator:
Kamran Rafiq – Managing Director, GlobalData

Panelists:
  • Sjaak Deckers – CEO, Sapiens
  • Ulf Pommerening – CEO, EBS Technologies
  • Dr Karl Schweitzer – VP and International General Manager, Medtronic Neuromodulation
Share this: Email this page Share this on LinkedIn Share this on Twitter
18:30–22:00 National Museum of the Italian Resorgimento, Palazzo Carignano

Evening Networking Reception
with Buffet Dinner

National Museum of the Italian Risorgimento, Palazzo Carignano
Via Accademia delle Scienze 5, 10123 Turin, Italy (map)
Entry from Piazza Carlo Alberto 8

Newly restored in 2011 for the 150th anniversary of Italian Unification, Palazzo Carignano housed the first Italian parliament and now offers visitors exhibitions recounting the period of the Risorgimento from a European viewpoint, as well as through the eyes of Turin, Piedmont and Italy.

The Museum is within 10 minutes walk of the conference center.

Sponsored by:
BioPmed BioPmed Torino Chamber of Commerce Torino Chamber of Commerce

Tuesday, May 17, 2011

07:30 Registration Opens/Continental Breakfast
09:00–10:00 Panel Discussion
The Perfect Storm: Europe's Opportunity

A favorable regulatory environment. A head start on the BRIC countries. Ample resources for innovation. A wobbling but still standing investment community. All of these factors combine to create a unique window of opportunity for the European healthcare industry. With a difficult regulatory environment in the USA leading to a longer and more expensive route to market than many young companies can afford, Europe is quickly becoming the first location to launch products, run clinical trials and often turn to for investment. How can medtech companies, both European and international, capitalize on this situation? The model of US companies setting up shop in Europe, with VCs who can take advantage of available soft funding for portfolio companies and use ample clinical data from European studies for later US approval is gaining traction. Will American VCs follow this wave and be more willing to invest or co-invest with their European counterparts, flipping the old model upside down?

How can Europe maintain its unique position as a leading innovative environment in the face of rising competition from China, Brazil and India, whose huge resources (and markets) are only starting to impact their healthcare systems? The opportunity is there for the taking: What do European regulators, companies, investors and healthcare providers need to do to take advantage of it?

Moderator:
Robert Keefer – Partner, TCG

Panelists:
  • Ruediger Herrmann – Partner, WilmerHale
  • Marion Jung – Principal, Earlybird Venture Capital
  • Bill Starling – CEO, Synecor
  • Klaus Stoeckemann – Managing Partner, Charité Biomedical Fund, c/o Peppermint Venture Partners
Share this: Email this page Share this on LinkedIn Share this on Twitter
09:00–17:00
One-to-one Meetings
10:15–11:15 Company Presentations
11:30–12:30 Panel Discussion
Growth Infrastructure: Are Clusters Useful for Company Growth?

The cluster model is an oft touted mechanism of innovation and SME support, but what is the reality of growing a company with such a mechanism? Can the geographical proximity of small and large companies, investors or fund providers, research facilities and personnel really play an instrumental role in helping a company grow, especially in an increasingly digitally connected world? This panel will provide case studies of companies whose cluster involvement was crucial to their growth and success and explore why clusters can play an important role in the development of companies of all sizes in spite of, or perhaps because of, increasing global interconnection.

Moderator:
Fabrizio Conicella – General Manager, Bioindustry Park Silvano Fumero and BioPmed Cluster

Panelists:
  • Yanis Caritu – Co-Founder and Software Fellow, Movea
  • Piero Costa – Head of Research and Development, Traumavet
  • Michael Vardi – CEO and Co-Founder, EStimME
Share this: Email this page Share this on LinkedIn Share this on Twitter
12:30–13:30 Luncheon
13:30–14:30 Panel Discussion
Trends and Perspectives in Surgical Innovation

Surgically innovative procedures are increasingly incorporating a variety of tools from other medtech sectors not traditionally seen in the operating room. With the use of NOTES and other minimally invasive techniques, imaging capabilities, ICT technologies and robotics have become integral parts of procedures and have also resulted in systems that are transforming the way surgeons are trained and their preparation for surgeries. This panel will discuss the major advances made possible by innovation in surgical tools and procedures, how these advances provide opportunities for medtech companies and what the increasing integration of different systems means for how companies will do business in the future.

Moderator:
André-Michel Ballester – CEO, Sorin Group

Panelists:
  • Paula Gomes – Global Medical Technology Practice, Cambridge Consultants
  • Andrea Venturelli – VP Research and Development, CTO Business Unit, Medtronic Peripheral
Share this: Email this page Share this on LinkedIn Share this on Twitter
14:45–15:45 Company Presentations
16:00–17:00 Panel Discussion
The Issue of Interoperability: How Innovation Depends on System Communication

As medical device innovation reaches further into the IT field to deliver the tools and processes needed to provide quality healthcare at lower costs, a major hurdle to overcome is interoperability between those same tools and processes. Touching everything from electronic medical records (EMR) to imaging systems to home monitoring devices, the need for healthcare tools to seamlessly communicate has become increasingly important for hospitals, physicians and patients. More importantly, the interoperability hurdle can determine the access companies have to their target market, with a lack of interoperabiltiy resulting in smaller companies being squeezed out and a decrease, not just in system choice, but also in overall access to innovation.

This panel will explore the specific characteristics of the medtech industry that make this issue paramount for future innovation, the key players needed to make interoperability a success, the effect of adopting interoperability standards on how medical technology companies do business, and the way interoperability will allow the next generation of medical technologies to meet the challenges of the changing healthcare landscape.

Moderator:
Prof Dr Erwin Keeve – Director Clinical Navigation, Charité Universitaetsmedizin Berlin

Panelists:
  • Joe Cafazzo – Lead, Centre for Global eHealth Innovation, University Health Network, University of Toronto
  • Marco Mattiuzzi – Technology Integration Manager, Bracco Imaging
  • Juan Soto – Senior Research Scientist, Fraunhofer Institute FOKUS
Share this: Email this page Share this on LinkedIn Share this on Twitter
17:00 Closing Reception
Sponsored by:
ADEBAG (Association for the Development of Bioindustry in the Grenoble Area) ADEBAG (Association for the Development of Bioindustry in the Grenoble Area) Ville de Grenoble Ville de Grenoble Grenoble Alpes Metropole Grenoble Alpes Metropole

Host Sponsors of EuroMedtech 2012
May 31–June 1, 2012 Grenoble, France

Arrow Up


© 2009–2012 EBD Group AG
EBD GroupEBD Group